The recruitment of circulating endothelial progenitor cells (EPCs)might have a beneficial effect on the clinical course of severaldiseases. Endothelial damage and detachment of endothelial cells areknown to occur in infection, tissue ischemia, and sepsis. These detrimentaleffects in EPCs are unknown. Here we elucidated whetherhuman EPCs internalize Bartonella henselae constituting a circulatingniche of the pathogen. B. henselae invades EPCs as shown by gentamicinprotection assays and transmission electron microscopy(TEM). Dil-Ac-LDL/lectin double immunostaining and fluorescenceactivatedcell sorting (FACS) analysis of EPCs revealed EPC bioactivityafter infection with B. henselae. Nitric oxide (NO) and its precursorL-arginine (L-arg) exert a plethora of beneficial effects on vascularfunction and modulation of immune response. Therefore, we testedalso the hypothesis that L-arg (1–30 mM) would affect the infection ofB. henselae or tumor necrosis factor (TNF) in EPCs. Our data provideevidence that L-arg counteracts detrimental effects induced by TNF orBartonella infections via NO (confirmed by DETA-NO and L-NMMAexperiments) and by modulation of p38 kinase phosphorylation.Microarray analysis indicated several genes involved in immuneresponse were differentially expressed in Bartonella-infected EPCs,whereas these genes returned in steady state when cells wereexposed to sustained doses of L-arg. This mechanism may have broadtherapeutic applications in tissue ischemia, angiogenesis, immuneresponse, and sepsis.

Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells

PAGLIARULO C;
2008

Abstract

The recruitment of circulating endothelial progenitor cells (EPCs)might have a beneficial effect on the clinical course of severaldiseases. Endothelial damage and detachment of endothelial cells areknown to occur in infection, tissue ischemia, and sepsis. These detrimentaleffects in EPCs are unknown. Here we elucidated whetherhuman EPCs internalize Bartonella henselae constituting a circulatingniche of the pathogen. B. henselae invades EPCs as shown by gentamicinprotection assays and transmission electron microscopy(TEM). Dil-Ac-LDL/lectin double immunostaining and fluorescenceactivatedcell sorting (FACS) analysis of EPCs revealed EPC bioactivityafter infection with B. henselae. Nitric oxide (NO) and its precursorL-arginine (L-arg) exert a plethora of beneficial effects on vascularfunction and modulation of immune response. Therefore, we testedalso the hypothesis that L-arg (1–30 mM) would affect the infection ofB. henselae or tumor necrosis factor (TNF) in EPCs. Our data provideevidence that L-arg counteracts detrimental effects induced by TNF orBartonella infections via NO (confirmed by DETA-NO and L-NMMAexperiments) and by modulation of p38 kinase phosphorylation.Microarray analysis indicated several genes involved in immuneresponse were differentially expressed in Bartonella-infected EPCs,whereas these genes returned in steady state when cells wereexposed to sustained doses of L-arg. This mechanism may have broadtherapeutic applications in tissue ischemia, angiogenesis, immuneresponse, and sepsis.
immune response; sepsis
File in questo prodotto:
File Dimensione Formato  
PNAS 2008 Salvatore, Casamassimi, Sommese et al.pdf

non disponibili

Licenza: Non specificato
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/20.500.12070/5410
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 28
social impact